Quote:
I wouldn't call a 62% efficiency a triumph but okay. I get it why the UK did approve it so quickly as it's homemade and they were really putting most of their eggs into the Astrazeneca basket.
Personally i would take either Pfizer or Moderna now and be on the lookout how good J&J is and Novavax.
No, 62% isn't great, and AZ (I don't think the problem's with the Oxford research team) do seem to have buggered up the trials, so the regulators say they don't have the data to approve the half-dose plus full-dose regime that gives 95%.
But the vaccine's far cheaper than Pfizer's and doesn't have Pfizer's insane storage requirements (my local GP surgery simply can't keep the Pfizer vaccine), so it should be much easier to achieve a fair degree of coverage.
And, if you think the UK's bad, polls in France suggest that 59% of citizens will refuse a vaccine. Remember their president is suave civilised Macron, not orange obstreperous Trump. Everybody knows the French are odd, but I have no idea what's going on there.